Udo Hoss,Shridhara Alva,Heather Pryor et al.
Udo Hoss et al.
Diabetic ketoacidosis (DKA) is a serious, life-threatening complication of diabetes. Although individuals who are at risk for DKA are advised to monitor ketone levels, adherence to monitoring is suboptimal. Continuous ketone monitoring is a...
Jennifer L Sherr,Erin C Cobry
Jennifer L Sherr
Diabetic ketoacidosis (DKA) is the most common acute complication and leading cause of mortality in children and adolescents with diabetes. While DKA is mainly seen in type 1 diabetes, youth with type 2 diabetes, especially adolescents, are...
Satish K Garg,Christopher G Parkin
Satish K Garg
Monitoring Ketonemia in People with Diabetes: Preliminary Findings from Real-World Studies [0.03%]
糖尿病患者的酮症监测：真实世界研究的初步结果
Richard M Bergenstal,Naunihal Virdi,Farhan Quadri et al.
Richard M Bergenstal et al.
Diabetic ketoacidosis (DKA) is a serious and potentially life-threatening complication of diabetes. While clinical trials and observational studies have traditionally included DKA events as part of their safety analyses, several studies hav...
Integrating Continuous Dual Glucose-Ketone Monitoring into Clinical Practice [0.03%]
连续性血糖-酮体监测在临床上的应用整合分析
Eden Miller,Kevin Miller,Richard M Bergenstal
Eden Miller
Diabetic ketoacidosis (DKA) is a life-threatening diabetes emergency associated with mortality and severe morbidities in individuals with diabetes. DKA mainly presents with significant hyperglycemia (>250 mg/dL); however, with the increasin...
Qaashif Panjwani,Anila Bindal
Qaashif Panjwani
Diabetic ketoacidosis (DKA) is a severe complication of diabetes, primarily affecting individuals with type 1 diabetes (T1D). However, one-third of hospitalized cases involve type 2 diabetes (T2D). Although DKA typically presents with hyper...
Viswanathan Mohan,Kenneth Lee
Viswanathan Mohan
Diabetic ketoacidosis (DKA) is a critical medical emergency, with an estimated annual incidence of 4%-8% among adults with type 1 diabetes (T1D). Up to 80% of children/adolescents
Mitigation Strategies for a Missed Meal Bolus in People with Type 1 Diabetes Using the Minimed ™ 780G System [0.03%]
针对使用美敦力680G系统的1型糖尿病患者错过餐前大剂量的补救策略
Bruno A Grassi,María Teresa Onetto,Germán Mora et al.
Bruno A Grassi et al.
Background: Postprandial glucose control remains a challenge in people with type 1 diabetes (T1D), even when using advanced hybrid closed-loop systems (AHCL) such as the MiniMed™ 780G (MM780G) system. Missed mealtime boluses are common and...
Automated Insulin Delivery Beyond Glycemic Outcomes: Endpoints and Evidence [0.03%]
自动化胰岛素输注治疗的结局指标及证据分析：超越血糖指标
Hanna C Jones,Steven Trawley,Alicia J Jenkins et al.
Hanna C Jones et al.
Automated insulin delivery (AID) systems have been shown to be an effective therapeutic option for people with type 1 diabetes and, more recently, for people with type 2 diabetes. To date, the benefit of AID systems has been primarily asses...
Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes [0.03%]
Control-IQ+自动化胰岛素输注在简化餐时输注策略下对成人2型糖尿病患者安全且有效
Carol J Levy,Lauren Kanapka,Sue A Brown et al.
Carol J Levy et al.
Objective: To characterize simplified meal bolus strategies in adults with insulin-treated type 2 diabetes using automated insulin delivery (AID). Research Design and Methods: In the 2IQP study, a 13-week randomized, controlled trial compar...